4 small cap ASX shares that could be stars of the future

Bigtincan Holdings Ltd (ASX:BTH) and these ASX small cap shares could be stars of the future…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Earlier today I looked at how successful small cap investing can be if you can identify a start of the future.

With that in mind, I thought I would pick out several small cap shares which I believe have significant potential and could generate outsized returns for investors in the future.

Here are four small cap shares to watch:

Alcidion Group Ltd (ASX: ALC)

Alcidion is an informatics solutions company to watch in the 2020s. It provides software which aims to improve the efficacy and cost of delivering services to patients and reduce hospital-acquired complications. I feel it is well placed for growth thanks to the growing trend for healthcare organisations to shift to a paperless environment.

Bigtincan Holdings Ltd (ASX: BTH)

Bigtincan is a provider of enterprise mobility software. Its software allows sales and service organisations to increase their sales win rates, reduce costs, and improve customer satisfaction through improved mobile worker productivity. Last year Bigtincan added to its blue chip customer base with agreements with sports giant Nike and global beauty retailer Sephora. I believe this is a testament to the quality of its product and bodes well for its performance in FY 2020 and beyond.

Opthea Ltd (ASX: OPT)

Another small cap to watch is Opthea. It is a developer of novel biologic therapies for the treatment of eye diseases. Last year the Phase 2b study of its OPT-302 combination therapy delivered exceptionally strong results. If its phase 3 results are equally successful, OPT-302 could generate significant revenues. Current standard of care treatments for wet age-related macular degeneration and diabetic macular edema had sales of over US$3.7 billion and US$6.2 billion in 2018.

Volpara Health Technologies Ltd (ASX: VHT)

A final small cap to watch is Volpara. It is a provider of software that uses artificial intelligence imaging algorithms to assist with the early detection of breast and lung cancer. The software continues to grow in popularity with radiologists across North America, leading to its recurring revenues increasing at a rapid rate. I expect this positive trend to continue this year, especially given its recent acquisitions.

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of Alcidion Group Ltd, BIGTINCAN FPO, and VOLPARA FPO NZ. The Motley Fool Australia has recommended Alcidion Group Ltd, BIGTINCAN FPO, and VOLPARA FPO NZ. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Speculative

Speculative

Bell Potter says this speculative ASX stock can rocket 40%

If you have a high tolerance for risk, then it could be worth checking out Vitrafy Life Sciences Ltd (ASX:…

Read more »

Man pointing an upward line on a bar graph symbolising a rising share price.
Speculative

Why this speculative ASX stock could rise ~50%

Bell Potter sees potential for big returns over the next 12 months.

Read more »

A bearded man holds both arms up diagonally and points with his index fingers to the sky with a thrilled look on his face over these rising Tassal share price
Speculative

These speculative ASX mining stocks could rise 85%+

Bell Potter has put speculative buy ratings on these stocks this morning.

Read more »

surprised asx investor appearing incredulous at hearing asx share price
Speculative

'Blockbuster opportunity': This speculative ASX stock could rise 70%

Bell Potter thinks exciting times could be around the corner for this buy-rated high risk stock.

Read more »

A smiling businessman in the city looks at his phone and punches the air in celebration of good news.
Healthcare Shares

Buy this small cap ASX stock with a 'lucrative opportunity'

Bell Potter thinks this speculative stock could have major upside thanks to its US market opportunity.

Read more »

Man drawing an upward line on a bar graph symbolising a rising share price.
Speculative

Broker says this speculative ASX stock could rise over 200%

This high risk option could have major upside according to analysts.

Read more »

Vanadium Resources share price person riding rocket indicating share price increase
Speculative

Meet the speculative ASX stock tipped to rise 180%

Bell Potter thinks this share could almost triple in value.

Read more »

People sit in rollercoaster seats with expressions of fear, terror and exhilaration as it goes into a steep downward descent representing the Novonix share price in FY22
AI Stocks

Brainchip share price tumbles 40% in the past year. What's next?

Brainchip shares have had a topsy-turvy year. So, what’s next for this speculative ASX AI technology stock?

Read more »